文献速递肝病消化道肿瘤与早癌

线粒体靶向与非线粒体靶向抗氧化剂通过改变小鼠DNA修复对肝癌发生产生矛盾效应

Contradictory effects of mitochondria- and non-mitochondria-targeted antioxidants on hepatocarcinogenesis by altering DNA repair in mice.
PubMed 文献 · Hepatology · 2018-01-07

该研究利用化学诱导肝癌小鼠模型,发现非线粒体靶向抗氧化剂N-乙酰半胱氨酸(NAC)和Trolox预防肿瘤发生,而线粒体靶向抗氧化剂SS-31和Mito-Q促进肿瘤发生。机制上,NAC和Trolox激活ATM/ATR减轻DNA损伤,SS-31和Mito-Q则使其失活加重损伤。

要点

  • 非线粒体靶向抗氧化剂NAC和Trolox在小鼠模型中预防化学诱导肝癌发生。
  • 线粒体靶向抗氧化剂SS-31和Mito-Q在小鼠模型中促进肝癌发生。
  • NAC和Trolox激活ATM/ATR修复DNA损伤,SS-31和Mito-Q则使其失活加重损伤。

核心结论

  • 抗氧化剂的类型在肝癌发生中发挥既往未被认识的作用,为探索抗氧化剂治疗肝癌提供了机制依据。

研究设计与样本

  • 研究利用化学诱导肝癌小鼠模型,并以二乙基亚硝胺(DEN)处理的原代肝细胞进行机制探讨。

主要发现

  • 在化学诱导肝癌小鼠模型中,给予非线粒体靶向抗氧化剂NAC和可溶性维生素E类似物Trolox预防了肿瘤发生,而给予线粒体靶向抗氧化剂SS-31(线粒体靶向肽)和Mito-Q(泛醌衍生物)促进了肿瘤发生。
  • RNA测序显示NAC和SS-31在氧化还原状态和DNA损伤应答方面引起非常不同的改变。
  • 在DEN处理的原代肝细胞中,NAC和Trolox通过激活ATM/ATR进行DNA修复而减轻DNA损伤,而SS-31和Mito-Q通过使其失活而加重损伤。
  • 部分恢复SS-31清除的线粒体活性氧(mtROS)可减轻SS-31加重的DNA损伤。
  • 阻断磷酸化ATR(p-ATR)导致NAC改善的DEN肝癌复发,而重新激活p-ATR则阻断了SS-31促进的DEN肝癌。

临床怎么用

  • 原文未据此给出临床推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Conflicting effects of antioxidant supplementation on cancer prevention or promotion is of great concern to healthy people and cancer patients. Despite recent studies about antioxidants accelerating the progression of lung cancer and melanoma, antioxidants may still play a role in cancer prevention. Both tumor and antioxidants types influence the actual efficacy. However, little is known about the impact of different types of antioxidants on primary hepatocellular carcinoma (HCC), including non-mitochondrial- and mitochondrial-targeted antioxidants. Utilizing mouse models of chemical hepatocarcinogenesis, we showed that administration of non-mitochondria-targeted antioxidants N-acetylcysteine (NAC) and the soluble vitamin E analog, Trolox, prevented tumorigenesis, whereas administration of mitochondria-targeted antioxidants SS-31 (the mitochondria-targeted peptide) and Mito-Q (a derivative of ubiquinone) facilitated tumorigenesis. RNA sequencing revealed that NAC and SS-31 caused very different changes in the oxidation-reduction state and DNA damage response. In diethylnitrosamine (DEN)-treated primary hepatocytes, NAC and Trolox alleviated DNA damage by activating ataxia-telangiectasia mutated (ATM)/ATM and Rad3-related (ATR) for DNA repair whereas SS-31 and Mito-Q aggravated damage by inactivating them. Interestingly, partial recovery of SS-31-scavengened mitochondrial reactive oxygen species (mtROS) could alleviate SS-31-aggravated DNA damage. Localization of ATM between mitochondria and nuclei was altered after NAC and SS-31 treatment. Furthermore, blockage of phospho-ATR (p-ATR) led to the recurrence of NAC-ameliorated DEN HCC. In contrast, reactivation of p-ATR blocked SS-31-promoted DEN HCC. Conclusion: These results demonstrate that the type of antioxidants plays a previously unappreciated role in hepatocarcinogenesis, and provide a mechanistic rationale for exploring the therapeutic use of antioxidants for liver cancer. (Hepatology 2018;67:623-635).

来源:Hepatology,查看原文。版权归原作者所有。

引用

  1. Wang B, Fu J, Yu T, et al. Contradictory effects of mitochondria- and non-mitochondria-targeted antioxidants on hepatocarcinogenesis by altering DNA repair in mice. Hepatology. 2018. PMID: 28898446. doi:10.1002/hep.29518

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。